SCHEMBL6507930

SCHEMBL6507930

COc1cc2c(c(OC)c1)C(c1ccco1)N(S(=O)(=O)c1ccc(OC(F)(F)F)cc1)CC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TAS2R14 Q9NYV8 2/20 0.41
HCRTR1 O43613 3/20 0.41
HCRTR2 O43614 2/20 0.41
MMP1 P03956 4/20 0.40
MMP9 P14780 4/20 0.40
MMP13 P45452 2/20 0.40
FKBP1A P62942 6/20 0.39
MMP7 P09237 2/20 0.39
MMP2 P08253 2/20 0.39
MMP12 P39900 2/20 0.39
MMP14 P50281 2/20 0.39
MMP15 P51511 2/20 0.39
MMP16 P51512 2/20 0.39
MMP26 Q9NRE1 2/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
PKM P14618 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13972857 0.84 TAS2R14 (0.49) NPSR1L3MBTL1TAS2R14HCRTR1HCRTR2
SCHEMBL4552332 0.84 TAS2R14 (0.49) NPSR1L3MBTL1TAS2R14HCRTR1HCRTR2
SCHEMBL4414378 0.83 PKM (0.41) TAS2R14FKBP1ALMNAPKM
SCHEMBL4412965 0.82 HCRTR1 (0.44) NPSR1L3MBTL1TAS2R14HCRTR1HCRTR2
SCHEMBL4421998 0.81 CA1 (0.46) L3MBTL1FKBP1ALMNAMEN1KMT2A
SCHEMBL4425654 0.80 TAS2R14 (0.43) L3MBTL1TAS2R14MMP1MMP9MMP13
SCHEMBL4411990 0.79 ALDH1A1 (0.47) FKBP1ALMNAPKMMEN1KMT2A
SCHEMBL4425647 0.79 GRIN2C (0.47) L3MBTL1FKBP1ATSHRMEN1KMT2A
SCHEMBL4413290 0.78 ALDH1A1 (0.41) HCRTR1HCRTR2FKBP1A
SCHEMBL4424185 0.78 LMNA (0.42) NPSR1HCRTR1HCRTR2MMP9MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070570-A1 Novel potassium channels modulators 4SC AG (DE) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070570-A1 Novel potassium channels modulators HCN4, KCNA4, KCNN4 NPSR1 155/4885L3MBTL1 2533/4885TAS2R14 514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.